Equities

Kits Eyecare Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Kits Eyecare Ltd

Actions
Consumer DiscretionaryConsumer Discretionary
  • Price (CAD)18.95
  • Today's Change0.48 / 2.60%
  • Shares traded47.45k
  • 1 Year change+112.21%
  • Beta0.2558
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Kits Eyecare Ltd. is a Canada-based provider of vertically integrated and digitally native eyecare platforms. The Company operates through the sale of eyewear products to consumers. It offers customers access to a selection of contact lenses and eyeglasses, including its own KITS-designed products, as well as an advanced suite of online vision tools. Its collections include KITS x Vasuma. The Company's designer glasses and sunglasses include Alexander McQueen, Armourx, Betsey Johnson, Bottega Veneta, Calvin Klein Carrera, David Beckham, Diesel, Dior, Emilio Pucci, Emporio Armani, Gucci, Hugo Boss, Jimmy Choo, Judith Leiber, Kits, Persol, Prada, Ray-Ban, Superdry, Tom Ford, Under Armour, and Versace. The Company also provides an Autoship subscription program for contact lenses and online eyewear fitting tools, virtual try-ons for glasses, and an integrated online vision test.

  • Revenue in CAD (TTM)193.40m
  • Net income in CAD5.58m
  • Incorporated2018
  • Employees162.00
  • Location
    Kits Eyecare Ltd510 Seymour Street, Suite 1020VANCOUVER V6B 3J5CanadaCAN
  • Phone+1 (604) 235-5550
  • Websitehttps://www.kits.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Kits Eyecare Ltd193.40m5.58m611.46m162.00116.249.8275.253.160.1630.1635.781.932.006.3282.121,193,827.005.76-6.138.66-9.1935.9531.372.88-4.700.723--0.1042--32.2233.99240.68125.8726.00--
AutoCanada Inc4.48bn88.71m615.33m6.00k6.991.274.340.13733.80-0.373191.5620.961.543.9026.00--3.112.815.925.3816.7117.152.021.430.41861.690.78280.802-4.569.01-45.65--2.15--
Pet Valu Holdings Ltd1.14bn97.34m1.96bn2.19k20.5924.6811.691.711.381.3816.241.151.165.5315.40--9.8711.3912.2315.7733.3435.328.518.950.53095.320.910519.693.9113.85-2.3845.6738.88--
Data as of Feb 13 2026. Currency figures normalised to Kits Eyecare Ltd's reporting currency: Canadian Dollar CAD

Institutional shareholders

13.12%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 31 Dec 20251.40m4.35%
Matco Financial, Inc.as of 31 Dec 2024988.00k3.06%
1832 Asset Management LPas of 30 Nov 2025636.35k1.97%
PenderFund Capital Management Ltd.as of 30 Jun 2025375.00k1.16%
Mackenzie Financial Corp.as of 05 Feb 2026255.91k0.79%
iA Global Asset Management, Inc.as of 30 Jan 2026183.46k0.57%
Spartan Fund Management, Inc.as of 30 Jun 2025168.50k0.52%
Hood River Capital Management LLCas of 30 Sep 2025104.00k0.32%
Vancity Investment Management Ltd.as of 31 Dec 202562.76k0.19%
Fiera Capital Corp. (Investment Management)as of 31 Dec 202556.50k0.18%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.